From: Augmented reality for stroke rehabilitation during COVID-19
Variables | AR-All | AR-Centre | AR-Home | p Value |
---|---|---|---|---|
 | (n = 39) | (n = 23) | (n = 16) |  |
Age (yrs)†| 63.54 ± 12.23 | 62.79 ± 13.79 | 64.61 ± 9.90 | 0.654 |
Gender (male/female) | 21/18 | 10/13 | 11/5 | 0.218 |
Affected side (left/right) | 10/29 | 7/16 | 3/13 | 0.480 |
Stroke type (isch./hemo.) | 26/13 | 15/8 | 11/5 | 1.000 |
Time from Stroke Onset (yrs)†| 3.51 ± 2.67 | 3.41 ± 2.72 | 3.67 ± 2.67 | 0.764 |
FMA-UE (max. 66)†| 38.85 ± 19.98 | 40.09 ± 19.69 | 37.06 ± 20.91 | 0.648 |
FMA-LE (max. 34)†| 18.64 ± 8.26 | 19.47 ± 8.18 | 17.44 ± 8.50 | 0.455 |
BBS (max. 56)†| 40.90 ± 11.87 | 41.35 ± 13.05 | 40.25 ± 10.32 | 0.781 |
FAC (max. 6)†| 4.54 ± 1.17 | 4.65 ± 1.19 | 4.38 ± 1.15 | 0.473 |
BI (max. 20)†| 16.31 ± 2.73 | N/A | 16.31 ± 2.73 | N/A |
SF-12v2 PCS (max. 100)†| 32.28 ± 12.25 | 32.75 ± 14.09 | 31.61 ± 9.39 | 0.779 |
SF-12v2 MCS (max. 100)†| 40.60 ± 17.25 | 37.07 ± 19.29 | 45.68 ±12.68 | 0.127 |